Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefaan Rossenu

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|July 8, 2011
A time scaling approach to develop an in vitro-in vivo correlation (IVIVC) model using a convolution-based techniqueCian Costello, Stefaan Rossenu, An Vermeulen, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 9, 2021
Exposure-safety analysis of QTc interval and transaminase levels following bedaquiline administration in patients with drug-resistant tuberculosisLénaïg Tanneau, Elin M Svensson, Stefaan Rossenu, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 5, 2024
Translational population target binding model for the anti-FcRn fragment antibody efgartigimodSven Hoefman, Tamara van Steeg, Ingrid Ottevaere, et al.
Journal of Biopharmaceutical Statistics|November 11, 2008
Combined models for data from in vitro-in vivo correlation experimentsTom Jacobs, Stefaan Rossenu, Adrian Dunne, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2018
A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of PosaconazoleMarlou L P S van Iersel, Stefaan Rossenu, Rik de Greef, et al.
Journal of Clinical Pharmacology|May 15, 2021
Population Pharmacokinetic Analysis of Bedaquiline-Clarithromycin for Dose Selection Against Pulmonary Nontuberculous Mycobacteria Based on a Phase 1, Randomized, Pharmacokinetic StudyKen Kurosawa, Stefaan Rossenu, Jeike Biewenga, et al.
Molecular Pharmaceutics|January 5, 2021
Linking <i>In Vitro</i> Intrinsic Dissolution Rate and Thermodynamic Solubility with Pharmacokinetic Profiles of Bedaquiline Long-Acting Aqueous Microsuspensions in RatsVy Nguyen, Jan Bevernage, Nicolas Darville, et al.
Psychopharmacology|July 10, 2012
D₂-receptor occupancy measurement of JNJ-37822681, a novel fast off-rate D₂-receptor antagonist, in healthy subjects using positron emission tomography: single dose versus steady state and dose selectionMark E Schmidt, Peter de Boer, Randolph Andrews, et al.
The Journal of Biological Chemistry|February 28, 2003
A phage display-based method for determination of relative affinities of mutants. Application of the actin-binding motifs in thymosin beta 4 and the villin headpieceStefaan Rossenu, Shirley Leyman, Daisy Dewitte, et al.
CNS Drugs|March 5, 2017
Dosing and Switching Strategies for Paliperidone Palmitate 3-Month Formulation in Patients with Schizophrenia Based on Population Pharmacokinetic Modeling and Simulation, and Clinical Trial DataMats O Magnusson, Mahesh N Samtani, Elodie L Plan, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Pharmacokinetics and Pharmacodynamics|July 8, 2011
A time scaling approach to develop an in vitro-in vivo correlation (IVIVC) model using a convolution-based techniqueCian Costello, Stefaan Rossenu, An Vermeulen, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 9, 2021
Exposure-safety analysis of QTc interval and transaminase levels following bedaquiline administration in patients with drug-resistant tuberculosisLénaïg Tanneau, Elin M Svensson, Stefaan Rossenu, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 5, 2024
Translational population target binding model for the anti-FcRn fragment antibody efgartigimodSven Hoefman, Tamara van Steeg, Ingrid Ottevaere, et al.
Journal of Biopharmaceutical Statistics|November 11, 2008
Combined models for data from in vitro-in vivo correlation experimentsTom Jacobs, Stefaan Rossenu, Adrian Dunne, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2018
A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of PosaconazoleMarlou L P S van Iersel, Stefaan Rossenu, Rik de Greef, et al.
Journal of Clinical Pharmacology|May 15, 2021
Population Pharmacokinetic Analysis of Bedaquiline-Clarithromycin for Dose Selection Against Pulmonary Nontuberculous Mycobacteria Based on a Phase 1, Randomized, Pharmacokinetic StudyKen Kurosawa, Stefaan Rossenu, Jeike Biewenga, et al.
Molecular Pharmaceutics|January 5, 2021
Linking <i>In Vitro</i> Intrinsic Dissolution Rate and Thermodynamic Solubility with Pharmacokinetic Profiles of Bedaquiline Long-Acting Aqueous Microsuspensions in RatsVy Nguyen, Jan Bevernage, Nicolas Darville, et al.
Psychopharmacology|July 10, 2012
D₂-receptor occupancy measurement of JNJ-37822681, a novel fast off-rate D₂-receptor antagonist, in healthy subjects using positron emission tomography: single dose versus steady state and dose selectionMark E Schmidt, Peter de Boer, Randolph Andrews, et al.
The Journal of Biological Chemistry|February 28, 2003
A phage display-based method for determination of relative affinities of mutants. Application of the actin-binding motifs in thymosin beta 4 and the villin headpieceStefaan Rossenu, Shirley Leyman, Daisy Dewitte, et al.
CNS Drugs|March 5, 2017
Dosing and Switching Strategies for Paliperidone Palmitate 3-Month Formulation in Patients with Schizophrenia Based on Population Pharmacokinetic Modeling and Simulation, and Clinical Trial DataMats O Magnusson, Mahesh N Samtani, Elodie L Plan, et al.
Pageof 3